Search for Clinical Trial Results
Purpura, Thrombotic Thrombocytopenic - 25 Studies Found
Status | Study |
Terminated |
Study Name: Safety and Efficacy Study to Compare Uniplas With Cryosupernatant Plasma in Thrombotic Thrombocytopenic Purpura (TTP) Condition: Thrombotic Thrombocytopenic Purpura (TTP) Date: 2006-12-13 Interventions:
|
Completed |
Study Name: Phase 1 Dose Escalation, Single Dose Study to Assess Safety and Pharmacokinetics of BAX930 in Hereditary Thrombotic Thrombocytopenic Purpura (TTP) Condition: Hereditary Thrombotic Thrombocytopenic Purpura (TTP) Date: 2014-08-12 Interventions: Drug: Recombinant ADAMTS13 rADAMTS13 (a disintegrin and me |
Recruiting |
Study Name: Low Dose Rituximab in Thrombotic Thrombocytopenic Purpura Condition: Thrombotic Thrombocytopenic Purpura Date: 2012-03-08 Interventions: Biological: rituximab rituximab intravenously 100 mg every week for four doses |
Not yet recruiting |
Study Name: Octaplas Adult TTP Trial Condition: Thrombotic Thrombocytopenic Purpura Date: 2013-09-02 Interventions:
|
Terminated |
Study Name: Evaluating the Effectiveness of Adding Rituximab to Standard Treatment for Thrombotic Thrombocytopenic Purpura (TTP) Condition: Thrombotic Thrombocytopenic Purpura Date: 2008-11-26 Interventions:
|
Enrolling by invitation |
Study Name: A Pilot Study of N-acetylcysteine in Thrombotic Thrombocytopenia Purpura Condition:
Date: 2013-02-22 Interventions: Drug: N-Acetylcysteine IV administration of N-Acetylcysteine at 150mg/kg over 60 min first, then if well |
Recruiting |
Study Name: Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome) Condition:
|
Completed |
Study Name: ARC1779 Injection in Patients With Von Willebrand Factor-Related Platelet Function Disorders Condition:
|
Completed |
Study Name: Rituximab in Patients With Relapsed or Refractory TTP-HUS Condition:
|